Get the Stockscreener App
4.14
12.20%
0.45
Evolent Health Inc stock is traded at $4.14, with a volume of 6.41M.
It is up +12.20% in the last 24 hours and down -49.39% over the past month.
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.
See More
Previous Close:
$3.69
Open:
$3.67
24h Volume:
6.41M
Relative Volume:
1.80
Market Cap:
$462.03M
Revenue:
$2.35B
Net Income/Loss:
$-74.42M
P/E Ratio:
-4.4043
EPS:
-0.94
Net Cash Flow:
$150.93M
1W Performance:
-0.96%
1M Performance:
-49.39%
6M Performance:
-48.25%
1Y Performance:
-64.28%
1-Day Range:
$3.60
$4.23
1-Week Range:
$3.495
$4.23
52-Week Range:
$3.495
$13.62
Evolent Health Inc Stock (EVH) Company Profile
Name
Evolent Health Inc
Sector
Industry
Phone
571-389-6000
Address
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON
Compare EVH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EVH
Evolent Health Inc
|
4.14 | 411.81M | 2.35B | -74.42M | 150.93M | -0.94 |
|
VEEV
Veeva Systems Inc
|
244.06 | 44.34B | 3.08B | 860.33M | 1.33B | 5.1481 |
|
TEM
Tempus Ai Inc
|
70.29 | 11.69B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
101.91 | 8.68B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
50.42 | 8.74B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
35.74 | 6.66B | 906.14M | -52.62M | 89.62M | -0.3621 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-13-25 | Initiated | BMO Capital Markets | Outperform |
| Nov-13-25 | Upgrade | Stephens | Equal-Weight → Overweight |
| Jan-10-25 | Initiated | Needham | Buy |
| Dec-03-24 | Reiterated | BTIG Research | Buy |
| Nov-08-24 | Downgrade | Stephens | Overweight → Equal-Weight |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Aug-09-24 | Upgrade | Truist | Hold → Buy |
| Apr-22-24 | Initiated | Citigroup | Buy |
| Mar-01-24 | Initiated | Oppenheimer | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-06-23 | Initiated | JMP Securities | Mkt Outperform |
| Oct-16-23 | Initiated | UBS | Buy |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Nov-01-22 | Initiated | Truist | Hold |
| Jul-29-22 | Initiated | RBC Capital Mkts | Outperform |
| Mar-30-22 | Initiated | Guggenheim | Buy |
| Nov-18-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-29-21 | Resumed | JP Morgan | Neutral |
| Jan-07-21 | Initiated | BTIG Research | Buy |
| Jul-06-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jun-05-20 | Downgrade | Goldman | Buy → Neutral |
| Jun-02-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Oct-05-18 | Resumed | Leerink Partners | Outperform |
| Jun-04-18 | Initiated | Piper Jaffray | Overweight |
| Apr-24-18 | Resumed | JP Morgan | Neutral |
| Sep-20-17 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jun-02-17 | Initiated | Robert W. Baird | Outperform |
| Mar-14-17 | Initiated | Oppenheimer | Outperform |
| Jan-13-17 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Oct-28-16 | Resumed | JP Morgan | Overweight |
| Aug-05-16 | Reiterated | FBR Capital | Outperform |
| Jul-26-16 | Initiated | Jefferies | Buy |
| Jul-13-16 | Reiterated | FBR Capital | Outperform |
| Mar-29-16 | Initiated | FBR Capital | Outperform |
| Jan-06-16 | Initiated | Canaccord Genuity | Buy |
| Jun-30-15 | Initiated | Goldman | Buy |
| Jun-30-15 | Initiated | JP Morgan | Overweight |
| Jun-30-15 | Initiated | Leerink Partners | Outperform |
| Jun-30-15 | Initiated | Sun Trust Rbsn Humphrey | Buy |
View All
Evolent Health Inc Stock (EVH) Latest News
Evolent Health Stock Gains Momentum Amid Strategic Moves - StocksToTrade
Citigroup Has Lowered Expectations for Evolent Health (NYSE:EVH) Stock Price - MarketBeat
Evolent Health Sees Uptrend with Analyst Upgrades and AI Initiatives - StocksToTrade
Evolent Health, American Oncology Network Partner to Streamline Cancer Care - MSN
Insulet, Guardant Health, agilon health, Evolent Health, and Myriad Genetics Stocks Trade Up, What You Need To Know - Yahoo Finance UK
Evolent Health (EVH): Citigroup Adjusts Price Target While Maint - GuruFocus
Can Evolent Health Inc. (9EH) stock ride next bull market cycleJuly 2025 Volume & Technical Entry and Exit Tips - newser.com
Evolent Health Inc (9EH.SG) Insider Ownership & Holdings - Yahoo! Finance Canada
Evolent Health (EVH) Price Target Decreased by 28.65% to 11.40 - MSN
Evolent Health (NYSE:EVH) Director Acquires $38,200.00 in Stock - MarketBeat
TD Cowen reaffirms Buy rating on Evolent Health stock amid selloff - Investing.com Canada
Stocks making big moves yesterday: Cogent, Wix, WESCO, LGI Homes, and Evolent Health - The Globe and Mail
Evolent Health: Overly Pessimistic Valuation Presents a Buy Opportunity Amidst Exaggerated Concerns - TipRanks
Can Evolent Health Inc. (9EH) stock hold up in economic slowdown2025 AllTime Highs & Daily Volume Surge Signals - newser.com
Engaged Capital takes new position in BlackLine, Cognex, lowers stake in Evolent Health in Q3 moves - MSN
Can Evolent Health Inc. (9EH) stock sustain revenue momentumPortfolio Performance Report & AI Based Trade Execution Alerts - newser.com
Applying Wyckoff theory to Evolent Health Inc. stockTrade Risk Assessment & Daily Chart Pattern Signals - newser.com
Is Evolent Health Inc. stock oversold or undervaluedJuly 2025 Selloffs & Free High Return Stock Watch Alerts - newser.com
Is Evolent Health Inc. stock positioned well for digital economyEarnings Risk Summary & Advanced Technical Analysis Signals - newser.com
Why Evolent Health Inc. stock is popular among millennials - newser.com
Insider Buying: Brendan Springstubb Acquires Shares of Evolent H - GuruFocus
[Form 4] Evolent Health, Inc. Insider Trading Activity - Stock Titan
Why Evolent Health (EVH) Shares Are Sliding Today - TradingView
Evolent Health, Inc $EVH Shares Sold by Bank of New York Mellon Corp - MarketBeat
Evolent Health Inc. stock prediction for this weekJuly 2025 Sector Moves & Reliable Breakout Forecasts - newser.com
Will Evolent Health Inc. see short term momentumQuarterly Market Summary & Weekly Stock Breakout Alerts - newser.com
JPMorgan Chase & Co. Has Lowered Expectations for Evolent Health (NYSE:EVH) Stock Price - MarketBeat
3 Reasons to Sell EVH and 1 Stock to Buy Instead - Yahoo Finance
JP Morgan Lowers Evolent Health (EVH) Price Target to $7.00 | EV - GuruFocus
How Evolent Health Inc. stock reacts to Fed rate cutsTreasury Yields & Fast Exit and Entry Trade Guides - newser.com
Persistent Asset Partners Ltd Makes New Investment in Evolent Health, Inc $EVH - MarketBeat
Is Evolent Health Inc. stock ready for a breakout2025 Market Overview & Fast Gain Swing Alerts - newser.com
Evolent Health (NYSE:EVH) Price Target Cut to $9.00 by Analysts at Canaccord Genuity Group - MarketBeat
Is Evolent Health Inc. a candidate for recovery play2025 Trading Volume Trends & Fast Moving Market Watchlists - newser.com
Evolent Health Inc Stock (EVH) Financials Data
Revenue
Net Income
Cash Flow
EPS
11.42%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):